Dominik Escher

756 total citations
11 papers, 590 citations indexed

About

Dominik Escher is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Dominik Escher has authored 11 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Oncology. Recurrent topics in Dominik Escher's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). Dominik Escher is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). Dominik Escher collaborates with scholars based in Switzerland, United States and France. Dominik Escher's co-authors include Alcide Barberis, Adrian Auf der Maur, Annemarie Honegger, Andreas Plückthun, Walter Schaffner, W. Schaffner, Anne Schmidt, Andreas Wenzel, Francesco Bandello and Eric H. Souied and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and FEBS Letters.

In The Last Decade

Dominik Escher

11 papers receiving 560 citations

Peers

Countries citing papers authored by Dominik Escher

Since Specialization

Citations

This map shows the geographic impact of Dominik Escher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominik Escher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominik Escher more than expected).

Fields of papers citing papers by Dominik Escher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominik Escher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominik Escher. The network helps show where Dominik Escher may publish in the future.

Co-authorship network of co-authors of Dominik Escher

This figure shows the co-authorship network connecting the top 25 collaborators of Dominik Escher. A scholar is included among the top collaborators of Dominik Escher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominik Escher. Dominik Escher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration 2016 ·Ophthalmology ·Frank G. Holz, Pravin U. Dugel, Georges Weissgerber, Robin Hamilton, Rufino Silva, Francesco Bandello, Michael Larsen, Andreas Weichselberger, Andreas Wenzel, Anne Schmidt, Dominik Escher, Laura Sararols, Eric H. Souied	133
2	Affinity and Potency of RTH258 (ESBA1008), a Novel Inhibitor of Vascular Endothelial Growth Factor A for the Treatment of Retinal Disorders 2015 ·Investigative Ophthalmology & Visual Science ·(unknown), Gunther Spohn, G. M. Schmid, (unknown), (unknown), Patrik Maurer, Anne W. Schmidt, Dominik Escher	35
3	Penetration of a Topically Administered Anti–Tumor Necrosis Factor Alpha Antibody Fragment into the Anterior Chamber of the Human Eye 2013 ·Ophthalmology ·Michael Thiel, Andreas B. Wild, Martin Schmid, Oliver Job, Frank Bochmann, (unknown), (unknown), Annette M. Schmidt, Peter Lichtlen, Dominik Escher	20
4	Preclinical Pharmacology and Safety of ESBA1008, a Single-chain Antibody Fragment, Investigated as Potential Treatment for Age Related Macular Degeneration 2012 ·Investigative Ophthalmology & Visual Science ·Jacques Gaudreault, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Anne Schmidt, Dominik Escher	34
5	An adenovirus vector with a chimeric fiber incorporating stabilized single chain antibody achieves targeted gene delivery 2005 ·Gene Therapy ·Susan J. Hedley, Adrian Auf der Maur, (unknown), Dominik Escher, Alcide Barberis, Joel N. Glasgow, Joanne T. Douglas, Nikolay Korokhov, David T. Curiel	46
6	Direct in Vivo Screening of Intrabody Libraries Constructed on a Highly Stable Single-chain Framework 2002 ·Journal of Biological Chemistry ·Adrian Auf der Maur, Christian Zahnd, Franziska Fischer, Silvia Spinelli, Annemarie Honegger, Christian Cambillau, Dominik Escher, Andreas Plückthun, Alcide Barberis	74
7	Antigen‐independent selection of stable intracellular single‐chain antibodies 2001 ·FEBS Letters ·Adrian Auf der Maur, Dominik Escher, Alcide Barberis	51
8	Conservation of Glutamine-Rich Transactivation Function between Yeast and Humans 2000 ·Molecular and Cellular Biology ·Dominik Escher, (unknown), Alcide Barberis, Walter Schaffner	54
9	Correlation between in Vitro Stability and in Vivo Performance of Anti-GCN4 Intrabodies as Cytoplasmic Inhibitors 2000 ·Journal of Biological Chemistry ·(unknown), Adrian Auf der Maur, Dominik Escher, Annemarie Honegger, Alcide Barberis, Andreas Plückthun	110
10	Gene activation at a distance and telomeric silencing are not affected by yeast histone H1 1997 ·Molecular and General Genetics MGG ·Dominik Escher, W. Schaffner	27
11	Improved “Activator Trap” Method for the Isolation of Transcriptional Activation Domains from Random DNA Fragments 1996 ·BioTechniques ·Dominik Escher, Walter Schaffner	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact